A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors
Clinical trial NCT04679038 · UNKNOWN
Trial details
- NCT number
- NCT04679038
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2022-12-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.